Cargando…
Biomarkers in Alzheimer Disease and Other Dementias: What’s Next into Pathophysiology to Support Clinical Practice and Drug Development
Autor principal: | Bougea, Anastasia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611876/ https://www.ncbi.nlm.nih.gov/pubmed/36295535 http://dx.doi.org/10.3390/medicina58101374 |
Ejemplares similares
-
Editorial: Body fluid biomarkers in neurodegenerative studies: Novel insights into pathophysiology to support clinical practice and drug development
por: Bougea, Anastasia, et al.
Publicado: (2023) -
Cortical Circuitry and Synaptic Dysfunctions in Alzheimer's Disease and Other Dementias
por: Ranieri, Federico, et al.
Publicado: (2021) -
Biomarkers in Alzheimer's Disease and Lewy Body Disorders with Dementia
por: Leyhe, Thomas, et al.
Publicado: (2013) -
Association of Kidney Function With Development of Alzheimer Disease and Other Dementias and Dementia-Related Blood Biomarkers
por: Stocker, Hannah, et al.
Publicado: (2023) -
What Next
Publicado: (1889)